Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-18-000013
Filing Date
2018-02-13
Accepted
2018-02-13 15:23:17
Documents
26
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 sangui10q_20171231audit20180.htm 10-Q 252636
2 sangui10q_20171231audit20002.gif GRAPHIC 25414
3 f20171231_exhibit3101.htm EX-31 8117
4 f20171231_exhibit3102vedgar.htm EX-32 8684
5 f20171231exhibit3201vedgar.htm EX-32 4234
  Complete submission text file 0001551163-18-000013.txt   741629

Data Files

Seq Description Document Type Size
6 sgbi-20171231.xml EX-101.INS 42728
7 sgbi-20171231.xsd EX-101.SCH 6760
8 sgbi-20171231_cal.xml EX-101.CAL 13901
9 sgbi-20171231_def.xml EX-101.DEF 4698
10 sgbi-20171231_lab.xml EX-101.LAB 54601
11 sgbi-20171231_pre.xml EX-101.PRE 41016
Mailing Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025
Business Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025 011 49 1607 412717
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

EIN.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 18602779
SIC: 2834 Pharmaceutical Preparations